
Kalpana Vanam
Kalpana Vanam leads the US Regulatory division at Lupin and is responsible for the Generics, Biosimilars, and Specialty portfolio.
With over 35 years of regulatory experience, she drives product innovation from inception to market launch. Her expertise spans regulatory filings, securing approvals, and bringing complex products to market across various therapeutic fields.
Prior to joining Lupin, she held leadership roles at Glenmark, Sun Pharma, Pfizer, Sandoz, and Taro.


Global Privacy Control Detected
We have detected your Global Privacy Control (GPC) signal. In accordance with applicable privacy laws, we have automatically honored your preference and disabled all non-essential cookies and tracking.
Only necessary cookies required for the website to function are enabled.
Opt-Out Request Honored
We have respected your privacy preference. Your opt-out request through cookie settings or Global Privacy Control signal has been honored.
